Ukrainian cyclist Volodymyr Bileka emerged as a promising young racer and eventually rode for the Discovery Channel team from 2005 through 2007, competing alongside fellow Ukrainian Yaroslav Popovych. His professional career unraveled in 2008 when, on 3 May, he sent a resignation letter to Silence–Lotto management citing personal reasons. The real explanation later became public: Bileka had tested positive for EPO, an erythropoietin-based blood-doping agent associated with artificially increased red-blood-cell production and improved endurance. The positive test resulted in a two-year suspension, abruptly interrupting the career of a rider who had built his reputation on strong junior results and professional promise. After serving the ban, Bileka returned to competition in 2010 with lower-ranked teams, attempting to rebuild his career away from the sport’s highest-profile squads. The comeback was short-lived as well. In 2012, while riding for Torku Şeker Spor, he tested positive for pseudoephedrine during the opening stage of the Tour of Trakya. Although pseudoephedrine is a stimulant and can also appear in some cold medicines, the violation produced a second major disciplinary setback: a four-year suspension scheduled to run until 1 July 2016. The episode left Bileka’s career defined not merely by an early exit from an elite team, but by repeated anti-doping sanctions that pushed him permanently toward the margins of professional cycling.
Follow the sources
Status and citations are supplied by the archive. AI concept art is an interpretation, not historical evidence.